PEB Share Price
Open 0.50 Change Price %
High 0.51 1 Day 0.00 0.00
Low 0.49 1 Week -0.08 -14.04
Close 0.49 1 Month -0.10 -16.95
Volume 5092148 1 Year -0.11 -18.33
52 Week High 0.60
52 Week Low 0.43
PEB Important Levels
Resistance 2 0.51
Resistance 1 0.50
Pivot 0.50
Support 1 0.48
Support 2 0.47
NZE NewZealand Most Active Stocks
NPX 5.45 0.55%
NPX 5.45 0.55%
NPX 5.45 0.55%
TEL 2.87 0.00%
TEL 2.87 0.00%
TEL 2.87 0.00%
TEL 2.87 0.00%
PEB 0.49 0.00%
PEB 0.49 0.00%
PEB 0.49 0.00%
More..
NZE NewZealand Top Gainers Stocks
CAV 0.55 5.77%
CAV 0.55 5.77%
MLN 0.83 3.75%
BGR 4.18 3.47%
BGR 4.18 3.47%
BGR 4.18 3.47%
BFW 1.39 2.21%
CVT 5.55 1.83%
CVT 5.55 1.83%
PGW 0.60 1.69%
More..
NZE NewZealand Top Losers Stocks
SPY 0.18 -14.29%
SPY 0.18 -14.29%
SPY 0.18 -14.29%
ATM 3.32 -3.21%
ATM 3.32 -3.21%
ATM 3.32 -3.21%
ATM 3.32 -3.21%
ANZ 29.20 -2.50%
ANZ 29.20 -2.50%
AMP 5.30 -2.39%
More..

Pacific Edge Ltd (NZE: PEB)

PEB Technical Analysis 4
As on 29th May 2017 PEB Share Price closed @ 0.49 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.53 & Strong Sell for SHORT-TERM with Stoploss of 0.57 we also expect STOCK to react on Following IMPORTANT LEVELS.
PEB Target for May
1st Target up-side 0.61
2nd Target up-side 0.63
3rd Target up-side 0.64
1st Target down-side 0.57
2nd Target down-side 0.55
3rd Target down-side 0.54
Pacific Edge Ltd ( NZE NewZealand Symbol : PEB )
Sector : Healthcare And Other Stocks in Same Sector
SAN
7.11 0.06 (0.85 %)
LT : Buy
ST : Sell		 AMP
5.30 -0.13 (-2.39 %)
LT : Sell
ST : Strong Sell		 BLT
0.03 0.00 (0.00 %)
LT : Strong Sell
ST : Strong Sell		 BLT
0.03 0.00 (0.00 %)
LT : Strong Sell
ST : Strong Sell		 PHB
1.23 0.00 (0.00 %)
LT : Sell
ST : Sell
PEB Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.pacificedge.co.nz
PEB Address
PEB
 87 Saint David Street
PO Box 56
Dunedin, 9016
New Zealand
Phone: 64 3 479 5800
Fax: 64 3 479 5801
PEB Latest News
Pacific Edge Limited Full Year Results to 31 March 2017   Scoop.co.nz (press release)   - 24th May 17
Pacific Edge undertakes $8 million share placement   sharechat   - 15th Feb 17
Repeal plan risk for Pacific Edge   Otago Daily Times   - 05th Jan 17
Pacific Edge announces commercial launch of Cxbladder Monitor in the US   News-Medical.net   - 15th Dec 16
Pacific Edge looks to steady growth   Otago Daily Times   - 25th Aug 16
Pacific Edge widens annual loss as it chases US growth   The National Business Review   - 26th May 16
Pacific Edge Presents Positive Cxbladder Monitor™ Results   PR Newswire (press release)   - 17th May 16
Pacific Edge share price back near 46c   Otago Daily Times   - 09th Sep 15
Research Shows Pacific Edge's Cxbladder Detect Outperforms Other Non-Invasive ...   PR Newswire (press release)   - 26th May 15
Pacific Edge's Cxbladder Triage™ Accurately Stratifies Patients with Bladder ...   PR Newswire (press release)   - 19th May 15
Interactive Technical Analysis Chart Pacific Edge Ltd ( PEB NZE NewZealand )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pacific Edge Ltd
PEB Business Profile
Pacific Edge Limited, a biomedical company, engages in the discovery, development, and commercialization of diagnostic and prognostic tools for the early detection and management of cancer. It offers Cxbladder, a non-invasive urine based test for the detection of bladder cancer; and Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The company’s products in development and clinical trial stage include gastric cancer diagnosis and prognosis, gastric cancer triage, and melanoma diagnosis and prognosis. It also manages and operates laboratories for the detection of bladder cancer. The company was formerly known as Pacific Edge Biotechnology Limited and changed its name to Pacific Edge Limited in April 2010. Pacific Edge Limited was founded in 2001 and is based in Dunedin, New Zealand.